Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 46 AL 60

Fluid biomarkers in the evolving care landscape of Alzheimer's disease and related disorders

Teunissen CE, Vermunt L, Barthélemy NR, Benzinger TLS, Graff-Radford J, Verberk IMW, Zetterberg H, Schindler SE, Jack CR Jr.

Lancet Neurol. 2026 Oct;25(10):926-938. doi: 10.1016/S1474-4422(26)00246-2.

Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy

Benzinger TLS, Cogswell PM, Arani A, Chaney AM, Hutson K, Glasser MF, Graff-Radford J, McConathy J, Raji CA, Teunissen C, Vemuri P, Zaharchuk G, Jack CR Jr.

Lancet Neurol. 2026 Oct;25(10):939-951. doi: 10.1016/S1474-4422(26)00285-1.

Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change

Graff-Radford J, Karliner L, Barnes DE, Frisoni GB, Sperling R, Villain N, Benzinger TLS, Teunissen C, Jack CR Jr.

Lancet Neurol. 2026 Oct;25(10):952-964. doi: 10.1016/S1474-4422(26)00248-6.

The complexities of diagnosing young-onset Alzheimer's dementia and the need for swift identification

Schild AK, Bartels C, Dodel R.

Expert Rev Neurother. 2026 Oct;26(10):923-941. doi: 10.1080/14737175.2026.2733193. Epub 2026 Sep 23.

Tau-PET correlates of mild behavioral impairment in preclinical and prodromal Alzheimer's disease: A head-to-head comparison of Flortaucipir and MK6240

Bizzi I, Macedo AC, Trudel L, Therriault J, Rahmouni N, Lussier FZ, Tissot C, Bezgin G, Aumont É, Chan T, Hosseini SA, Oliva-Lopez D, Gonçalves MP, Povala G, Ferreira PCL, Bellaver B, Amaral L, Ruppert E, Medeiros MS, Mroué R, Rocha A, Ng KP, Zimmer ER, Masdeu J, Pascual B, Lowe VJ, Oh H, Soleimani-Meigooni DN, Fortea J, Ismail Z, Baker S, Pascoal TA, Rosa-Neto P; HEAD Study.

Alzheimers Dement. 2026 Oct;22(10):e71861. doi: 10.1002/alz.71861.

Microglia-derived extracellular vesicle content as a biomarker for early detection of Alzheimer's disease

Woudstra AL, Holtman L, van Vliet EA.

Transl Neurodegener. 2026 Sep 30;15(1):51. doi: 10.1186/s40035-026-00587-9.

Exploring the role of glymphatic system in Alzheimer's disease with insights from MRI-based studies: a systematic review

Bernetti C, Calandrelli R, Pilato F, Di Lazzaro V, Zobel BB, D'Amelio M, Mallio CA.

Neuroradiology. 2026 Oct 3. doi: 10.1007/s00234-026-04206-2. Online ahead of print.

Multimodal PET/MRI radiomics model for the classification of Alzheimer's disease and other dementia subtypes: A multicenter study

Wang B, Bi S, Xu X, Zheng H, Liang D, Mok GSP, Yan S, Hu Z.

Med Phys. 2026 Oct;53(10):e70690. doi: 10.1002/mp.70690.

Longitudinal clinical outcomes after amyloid clearance in aducanumab phase 3 studies

Pang M, Brothers HM, O'Gorman J, Murphy J, Zabar Y, Lasky T, Shen C, Rubino I, Knopman D.

Alzheimers Dement. 2026 Oct;22(10):e71758. doi: 10.1002/alz.71758.

Plasma p-tau217 as a biomarker for Alzheimer's disease: diagnostic and prognostic value in clinical and population-based studies

Gerson G, Nogueira GN, Teixeira MJ.

Arq Neuropsiquiatr. 2026 Oct;84(10):1-8. doi: 10.1055/s-0046-1829032. Epub 2026 Oct 9.

A positive Alzheimer's blood biomarker is not a diagnosis: the presence-primacy-permission framework for plasma p-tau217

Bhatia V, Khatak A.

Ann Med Surg (Lond). 2026 Sep 8;88(10):6232-6234. doi: 10.1097/MS9.0000000000005661. eCollection 2026 Oct.

Blood-based multiplex nanobiosensing of Alzheimer's disease biomarkers: from nanoengineered ınterfaces to clinical translation

Pehlivan ZN, Zıkşahna K, Adıyıl R, Ihlamur M.

Metab Brain Dis. 2026 Oct 13;41(1):234. doi: 10.1007/s11011-026-01993-8.

Advancing early detection of Alzheimer's disease: from established biomarkers to future innovations

Qu L, Wang Y, Ren L, Zhang C, Guo Z, Zhang L, Pang X, Sha S.

Int Immunopharmacol. 2026 Oct 14;190:117537. doi: 10.1016/j.intimp.2026.117537. Online ahead of print.

Microglial dynamics associate with the spatial pattern of tau deposition in early Alzheimer's disease

Öchsner M, Brendel M, Franzmeier N, Trappmann L, Zaganjori M, Ersoezlue E, Kurz C, Haeckert J, Utecht J, Schirge PM, Papazov B, Pogarell O, Janowitz D, Buerger K, Ewers M, Palleis C, Weidinger E, Biechele G, Schuster S, Finze A, Eckenweber F, Rupprecht R, Rominger A, Goldhardt O, Grimmer T, Keeser D, Stoecklein S, Dietrich O, Bartenstein P, Levin J, Höglinger G, Perneczky R, Rauchmann BS.

Alzheimers Res Ther. 2026 Oct 12;18(1):232. doi: 10.1186/s13195-026-02230-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias